Metlife Overview
Metlife (MET) has a ROE of 13.02%, above the Finance sector average of 11.91%.
Get informed when a big investor buys or sells
+ Follow13.02%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
The latest ROE for MET is 13.02%. That is above the Finance sector average of 11.91%. Investors often review this figure alongside Metlife's historical trend and sector peers before judging valuation or financial health.
Against Finance companies, MET currently prints 13.02% for ROE, while the sector average sits near 11.91%. That is roughly 9.3% above the sector mean. Large gaps often invite a closer look at Metlife's growth, margins, and balance sheet.
Return on Equity shows how effectively Metlife converts resources into returns. At 13.02%, MET may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting MET's ROE (13.02%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack Metlife's ROE against similar Finance names. You can also browse sector and industry screens on Stockcircle for a broader set of Finance companies and their key multiples and fundamentals.
